Crispr Therapeutics shares owned by Virtus ETF Advisers
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Virtus ETF Advisers
from 13F filings
Historical chart of Virtus ETF Advisers investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Virtus ETF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $303k | 7.7k | 39.36 |
| 2024-09-30 | $237k | 5.0k | 46.98 |
| 2024-06-30 | $273k | 5.0k | 54.01 |
| 2024-03-31 | $413k | 6.1k | 68.16 |
| 2023-12-31 | $325k | 5.2k | 62.60 |
| 2023-09-30 | $76k | 1.7k | 45.39 |
| 2023-06-30 | $104k | 1.8k | 56.14 |
| 2023-03-31 | $91k | 2.0k | 45.23 |
| 2022-12-31 | $114k | 2.8k | 40.65 |
| 2022-09-30 | $117k | 1.8k | 65.18 |
| 2022-06-30 | $108k | 1.8k | 60.54 |
| 2022-03-31 | $131k | 2.1k | 62.95 |
| 2021-12-31 | $167k | 2.2k | 75.81 |
| 2021-09-30 | $184k | 1.6k | 111.92 |
| 2021-06-30 | $281k | 1.7k | 161.77 |
| 2021-03-31 | $244k | 2.0k | 121.82 |
| 2020-12-31 | $301k | 2.0k | 153.10 |
| 2020-09-30 | $431k | 5.2k | 83.61 |
| 2020-06-30 | $429k | 5.8k | 73.41 |
| 2020-03-31 | $233k | 5.5k | 42.39 |
| 2019-12-31 | $384k | 6.3k | 60.89 |
More positions owned by Virtus ETF Advisers
Globe Life (GL)
View all positions for Virtus ETF Advisers